These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3674901)

  • 1. [Treatment of myelodysplastic syndrome with alfacalcidol].
    Tagawa M; Ito H; Kuriyama K; Tomonaga M; Ichimaru M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3160-2. PubMed ID: 3674901
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study.
    Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
    Int J Clin Pharmacol Res; 1993; 13(1):21-7. PubMed ID: 8509233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
    Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
    Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment of myelodysplastic syndromes-refractory anemia with excess blasts type II by decitabine: a case report].
    Bao L; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):573. PubMed ID: 22967422
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of myelodysplastic syndrome with cyclosporin A.
    Chen S; Jiang B; Da W; Gong M; Guan M
    Int J Hematol; 2007 Jan; 85(1):11-7. PubMed ID: 17261496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observation on treatment of myelodysplastic syndromes with yisuikang].
    Guo PJ; Li GZ; Liu PL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Feb; 15(2):74-6. PubMed ID: 7787394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide in myelodysplastic syndromes.
    Zorat F; Pozzato G
    Biomed Pharmacother; 2002 Feb; 56(1):20-30. PubMed ID: 11905506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in patients with myelodysplastic syndromes.
    Schouten HC; Vellenga E; van Rhenen DJ; de Wolf JT; Coppens PJ; Blijham GH
    Leukemia; 1991 May; 5(5):432-6. PubMed ID: 2033964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of refractory myelodysplastic anemias: a Japanese Cooperative Study.
    Yoshida Y; Yamagishi M; Oguma S; Uchino H; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1448-54. PubMed ID: 3073616
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).
    Fukutani H; Naoe T; Saito H; Ohshima T; Omine M; Miura Y; Mizoguchi H; Kimura I; Tomonaga M; Ohno R
    Jpn J Clin Oncol; 1991 Aug; 21(4):287-92. PubMed ID: 1942558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
    Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
    Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myelodysplastic syndrome: treatment of 6 patients with 13-cis retinoic acid.
    Kerndrup G; Bendix-Hansen K; Pedersen B; Ellegaard J; Hokland P
    Scand J Haematol Suppl; 1986; 45():128-32. PubMed ID: 3457443
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of aggressive chemotherapy for myelodysplastic syndromes.
    Dohy H; Kyo T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness and safety of 5-azacitidine in three patients with myelodysplastic syndromes].
    Garzás-Martín de Almagro MC; Gago Sánchez AI; Cuevas Asencio I; Reyes Malia M
    Farm Hosp; 2010; 34(4):204-8. PubMed ID: 20185350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide for the treatment of patients with myelodysplastic syndromes.
    Strupp C; Germing U; Aivado M; Misgeld E; Haas R; Gattermann N
    Leukemia; 2002 Jan; 16(1):1-6. PubMed ID: 11840256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
    Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
    Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.